Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 213 JPY 0.29% Market Closed
Market Cap: 6.7T JPY
Have any thoughts about
Takeda Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Takeda Pharmaceutical Co Ltd

Wall Street analysts forecast Takeda Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 4 854.45 JPY with a low forecast of 4 242 JPY and a high forecast of 6 195 JPY.

Lowest
Price Target
4 242 JPY
1% Upside
Average
Price Target
4 854.45 JPY
15% Upside
Highest
Price Target
6 195 JPY
47% Upside
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
ERIS
Eris Lifesciences Ltd
2% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
20% Upside
CLSD
Clearside Biomedical Inc
453% Upside
PFE
Pfizer Inc
28% Upside
RHONEMA
Rhone Ma Holdings Bhd
1% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
42% Downside
600557
Jiangsu Kanion Pharmaceutical Co Ltd
68% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Takeda Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 2%.

11%
Past Growth
2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Takeda Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 19%.

9%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Takeda Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 27%.

8%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
4 854.45 JPY

According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 4 854.45 JPY with a low forecast of 4 242 JPY and a high forecast of 6 195 JPY.

What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 2%.

What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 19%.

What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 27%.

Back to Top